This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

Using Atypical Antipsychotics in Primary Care

Joseph A. Liberman III, Sally Berry, Larry Culpepper, Robert L. Findling, Stephen R. Marder, Del Miller, Jacobo E. Mintzer, Bruce L. Saltz, Zafar A. Sharif, and Stephen M. Stahl

Published: December 1, 2002

Article Abstract

Click to enlarge page

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Stephen R. Marder, M.D., addressed the efficacy of atypical antipsychotics. In a controversial study, Geddes and collaborators1 concluded that conventional antipsychotics should be firstline treatments except when motor side effects such as EPS are a problem. However, most patients treated with conventional agents will experience some of these adverse effects.

‘ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 4

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Insights

LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Using data from the...

Read More...